19-41999026-C-A
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_002088.5(GRIK5):c.2788G>T(p.Val930Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000435 in 943,034 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000039 ( 0 hom., cov: 30)
Exomes 𝑓: 0.000044 ( 0 hom. )
Consequence
GRIK5
NM_002088.5 missense
NM_002088.5 missense
Scores
1
5
13
Clinical Significance
Conservation
PhyloP100: 0.425
Genes affected
GRIK5 (HGNC:4583): (glutamate ionotropic receptor kainate type subunit 5) This gene encodes a protein that belongs to the glutamate-gated ionic channel family. Glutamate functions as the major excitatory neurotransmitter in the central nervous system through activation of ligand-gated ion channels and G protein-coupled membrane receptors. The protein encoded by this gene forms functional heteromeric kainate-preferring ionic channels with the subunits encoded by related gene family members. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.06505248).
BS2
High AC in GnomAd4 at 5 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GRIK5 | NM_002088.5 | c.2788G>T | p.Val930Leu | missense_variant | 20/20 | ENST00000593562.6 | NP_002079.3 | |
GRIK5 | XM_011526862.3 | c.2791G>T | p.Val931Leu | missense_variant | 20/20 | XP_011525164.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GRIK5 | ENST00000593562.6 | c.2788G>T | p.Val930Leu | missense_variant | 20/20 | 5 | NM_002088.5 | ENSP00000470251 | P1 | |
GRIK5 | ENST00000262895.7 | c.2788G>T | p.Val930Leu | missense_variant | 19/19 | 1 | ENSP00000262895 | P1 | ||
GRIK5 | ENST00000454993.6 | n.1665G>T | non_coding_transcript_exon_variant | 9/9 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000390 AC: 5AN: 128154Hom.: 0 Cov.: 30
GnomAD3 genomes
AF:
AC:
5
AN:
128154
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000139 AC: 2AN: 14398Hom.: 0 AF XY: 0.000227 AC XY: 2AN XY: 8822
GnomAD3 exomes
AF:
AC:
2
AN:
14398
Hom.:
AF XY:
AC XY:
2
AN XY:
8822
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000442 AC: 36AN: 814848Hom.: 0 Cov.: 26 AF XY: 0.0000455 AC XY: 18AN XY: 395958
GnomAD4 exome
AF:
AC:
36
AN:
814848
Hom.:
Cov.:
26
AF XY:
AC XY:
18
AN XY:
395958
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000390 AC: 5AN: 128186Hom.: 0 Cov.: 30 AF XY: 0.0000489 AC XY: 3AN XY: 61410
GnomAD4 genome
AF:
AC:
5
AN:
128186
Hom.:
Cov.:
30
AF XY:
AC XY:
3
AN XY:
61410
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 23, 2024 | The c.2788G>T (p.V930L) alteration is located in exon 19 (coding exon 19) of the GRIK5 gene. This alteration results from a G to T substitution at nucleotide position 2788, causing the valine (V) at amino acid position 930 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Uncertain
.;D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L
MutationTaster
Benign
D
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;.
REVEL
Benign
Sift
Uncertain
D;.
Sift4G
Benign
T;T
Polyphen
B;B
Vest4
MutPred
Loss of sheet (P = 0.0817);Loss of sheet (P = 0.0817);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at